| Literature DB >> 25582171 |
Chao Ye1,2, Nan Xu3,4, Haiqin Chen5,6, Yong Q Chen7,8, Wei Chen9,10, Liming Liu11,12.
Abstract
BACKGROUND: Mortierella alpina is an oleaginous fungus used in the industrial scale production of arachidonic acid (ARA). In order to investigate the metabolic characteristics at a systems level and to explore potential strategies for enhanced lipid production, a genome-scale metabolic model of M. alpina was reconstructed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25582171 PMCID: PMC4301621 DOI: 10.1186/s12918-014-0137-8
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
General features of model CY1106
|
|
|
|
|---|---|---|
| Genome feature | ||
| Genome size (Mb) | 38.38 | 38.38 |
| Total open reading frames (ORFs) | 11631 | 11631 |
| Metabolic model | ||
| Total reactions | 1854 | 1183 |
| Biochemical reactions | 1391 | 1183 |
| Transport reactions | 247 | none |
| Exchange reactions | 216 | none |
| Metabolites | 1732 | 1660 |
| ORFs associated in model | 1106 | 1042 |
| ORF coverageb (%) | 9.51 | 8.95 |
aThe existed model was constructed by Vongsangnak et al. [21]; bThe number of ORFs incorporated in model iCY1106 divided by the total number of ORFs.
Figure 1The comparison between Vongsangnak’s model and CY1106. a: reaction distribution in subsystems between these two models; b: shared reactions and unique reactions between models.
Figure 2Essential genes identified by MG and YE medium in model CY1106.
Essential genes identified on different mediums which are high homology with DEG
|
|
|
|
| |
|---|---|---|---|---|
|
|
| |||
| MA-133-4 | Ribose-5-phosphate isomerase | E | E | Carbohydrate metabolism |
| MA-090-485 | UTP-glucose-1-phosphate uridylyltransferase | E | E | |
| MA-101-200 | Mannose-6-phosphate isomerase | E | E | |
| MA-120-141 | Phosphoacetylglucosamine mutase | E | E | |
| MA-184-380 | Acetyl-CoA carboxylase | E | E | |
| MA-072-196 | Argininosuccinate lyase | E | NE | Amino acid metabolism |
| MA-213-50 | Adenylosuccinate synthase | E | E | |
| MA-213-539 | Adenylosuccinate lyase | E | E | |
| MA-326-6 | Aspartate carbamoyltransferase | E | E | |
| MA-334-434 | Phosphoribosylanthranilate isomerase | E | NE | |
| MA-120-148 | 2-Acetolactate methylmutase | E | NE | |
| MA-090-434 | Dihydroxy-acid dehydratase | E | NE | |
| MA-139-331 | Homoaconitate hydratase | E | NE | |
| MA-323-77 | Saccharopine dehydrogenase | E | NE | |
| MA-326-106 | Ornithine carbamoyltransferase | E | NE | |
| MA-101-393 | Imidazole-4-carboxamide isomerase | E | NE | |
| MA-184-558 | Imidazoleglycerol-phosphate dehydratase | E | NE | |
| MA-090-452 | Glutamine amidotransferase:cyclase | E | NE | |
| MA-320-159 | 3-dehydroquinate synthase | E | NE | |
| MA-139-157 | Chorismate synthase | E | NE | |
| MA-073-62 | 3-deoxy-7-phosphoheptulonate synthase | E | NE | |
| MA-213-547 | Tryptophan synthase | E | NE | |
| MA-297-40 | Chorismate mutase | E | NE | |
| MA-120-157 | Thioredoxin reductase | E | E | |
| MA-173-30 | Purine-nucleoside phosphorylase | E | E | Nucleotide metabolism |
| MA-213-65 | IMP dehydrogenase | E | E | |
| MA-120-261 | Nucleoside diphosphate kinase | E | E | |
| MA-139-347 | Guanylate kinase | E | E | |
| MA-120-138 | Ribonucleoside-diphosphate reductase | E | E | |
| MA-055-211 | Ribonucleoside-diphosphate reductase | E | E | |
| MA-323-58 | Ribonucleoside-diphosphate reductase | E | E | |
| MA-334-356 | Thymidylate synthase | E | E | |
| MA-153-455 | 3(2),5-bisphosphate nucleotidase | E | NE | |
| MA-111-23 | phosphoadenylyl-sulfate reductase | E | NE | Energy metabolism |
| MA-182-360 | 6,7-dimethyl-8-ribityllumazine synthase | E | E | Cofactors and vitamins |
| MA-184-368 | Riboflavin synthase | E | E | |
| MA-210-311 | Aspartate dehydrogenase | E | E | |
| MA-055-340 | Fatty-acyl-CoA synthase | E | E | Lipid metabolism |
| MA-162-131 | Palmitoyl-protein thioesterase | E | E | |
| MA-334-239 | Very-long-chain enoyl-CoA reductase | E | E | |
E: essential gene; NE: non-essential gene. MG: minimal medium; YE: yeast extract medium.
Comparison of and growth rates of .
|
|
|
| |
|---|---|---|---|
|
|
| ||
| Glc (v = 0.8) | 0.0696 | 0.0690 | [ |
| Glc (v = 2.0) | 0.1708 | 0.1546 | [ |
in vivo: experimental results; in silico: simulation results.
Figure 3Synthesis pathway of PUFAs in . . (accoa: acetyl-CoA, acp: acyl-carrier protein, acacp: Acetyl-[acyl-carrier protein], malcoa: malonyl-CoA, malacp: malonyl-[acp], aacacp: acetoacetyl [acp], c4hacp: (3R)-3-Hydroxybutanoyl-[acp], c4dacp: but-2-enoyl-[acp], c40acp: butanoyl-[acp], c6oacp: 3-oxohexanoyl-[acp], c6hacp: 3-hydroxyhexanoyl-[acp], c6dacp: hex-2-enoyl-[acp], c60acp: hexanoyl-[acp], c8oacp: 3-oxooctanoyl-[acp], c8hacp: 3-hydroxyoctanoyl-[acp], c8dacp: oct-2-enoyl-[acp], c80acp: octanoyl-[acp], c10oacp: 3-oxodecanoyl-[acp], c10hacp: 3-hydroxydecanoyl-[acp], c10dacp: dec-2-enoyl-[acp], c100acp: decanoyl-[acp], c12oacp: 3-oxododecanoyl-[acp], c12hacp: 3-hydroxy-dodecanoyl-[acp], c12dacp: dodec-2-enoyl-[acp], c120acp: dodecanoyl-[acp], c14oacp: 3-oxomyristoyl-[acp], c14dacp: tetradec-2-enoyl-[acp], c14hacp: 3-hydroxymyristoyl-[acp], c140acp: myristoyl-[acp], c16oacp: 3-oxohexadecanoyl-[acp], c16hacp: (3R)-3-Hydroxypalmitoyl-[acp], c16dacp: hexadec-2-enoyl-[acp], c160acp: hexadecanoyl-[acp], c160: palmitic acid, c160coa: hexadecanoyl-CoA, c180coa: octadecanoyl-CoA, c181coa: octadecenoyl-CoA, c182coa: linoleoyl-CoA, c183(6)coa: gamma-Linolenoyl-CoA, c203(6)coa: 8,11,14-Eicosatrienoyl-CoA, c204(6)coa: Arachidonyl-CoA, c204(6): ARA, c183(3)coa: alpha-Linolenoyl-CoA, c184(3)coa: Stearidonoyl-CoA, c204(3)coa: (11Z,14Z,17Z)-Icosatrienoyl-CoA, c205(3)coa: eicosapentaenoyl-CoA, c225(3)coa: (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA, c245(3)coa: (9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA, c246(3)coa: (6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA, c226(3)coa: (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA).
Figure 4The sources of acetyl-CoA in . . (cit: citrate, ac: acetate, llac: l-lactate, mal: malate, pep: phosphoenolpyruvate, pyr: pyruvate, accoa: acrtyl-CoA, asp: l-aspartate, bala: beta-alanine, oppa: 3-oxopropanoate, ile: l-isoleucine, omval: (s)-3-nethyl-2-oxopentanoate, mbcoa: 2-methylbutanoyl-CoA, mcrocoa: 2-methylcrotonoyl-CoA, metbycoa: (2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA, mcecoa: 2-Methylacetoacetyl-CoA, lys: l-lysine, sacp: l-saccharopine, amasa: l-2-aminoadipate 6-semialdehyde, ama: l-2-aminoadipate, aka: 2-oxoadipate, gltcoa: glutaryl-CoA, c4dcoa: crotonoyl-coa, c4hcoa: (S)-3-Hydroxybutanoyl-CoA, aaccoa: acetoacetyl-CoA, leu: l-leucine, 4mop: 4-methyl-2-oxopentanoate, ivacoa: 3-isovaleryl-coa, mcrcoa: 3-nethylcrotonyl-CoA, mgcoa: trans-3-methylglutaconyl-CoA, hmgcoa: (s)-3-hydroxy-3-methylglutaryl-coa).
Figure 5Changes of reactions involving NADPH at different ARA levels. (Different colors represent different changes on NADPH flux. Flux obviously changed reactions are listed. R2: D-glucose 6-phosphate + NADP ⬄ 6-phospho-D-glucono-1,5-lactone + NADPH + H, R3: 6-phospho-D-gluconate + NADP - > D-ribulose 5-phosphate + CO2 + NADPH + H, R4: (S)-malate + NADP - > pyruvate + CO2 + NADPH, R5: L-glutamate 5-semialdehyde + NAD P+ H2O - > L-glutamate + NADPH + H, R6: 1-pyrroline-5-carboxylate + NADPH + H ⬄ L-proline + NADP, R16: Nitrite + 3 NADPH + 5 H - > Ammonia + 3 NADP + 2 H2O, R51: N-acetyl-L-glutamyl 5-phosphate + NADPH + H ⬄ N-acetyl-L-glutamate 5-semialdehyde + NADP + Phosphate, R53: (S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H ⬄ (R)-mevalonate + CoA + 2 NADP).